News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Skyepharma PLC in Process of Filing Flutiform in EU
March 25, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LONDON, March 25 (Reuters) - British drug delivery specialist SkyePharma (SKP.L) said it was in the process of filing its Flutiform asthma drug for European approval, following recent setbacks in the United States.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
Europe
MORE ON THIS TOPIC
Opinion
2025 Reshaped the FDA. What Will 2026 Hold?
February 9, 2026
·
6 min read
·
Claire Davies
Policy
FDA Policy Tracker 2026: Priority Vouchers Questioned, PRVs Return
February 9, 2026
·
5 min read
·
Heather McKenzie
Drug pricing
TrumpRx Website Set To Launch Thursday Evening After Delay
February 5, 2026
·
1 min read
·
Dan Samorodnitsky
Job Trends
3 Top Challenges Facing Regulatory Professionals Right Now
February 5, 2026
·
4 min read
·
Angela Gabriel
